跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,864 条关于
“Debiopharm International”
全部
7,864
临床试验
2,412
药物
201
机构
508
资讯
4,743
去年
Repare Therapeutics Licenses PKMYT1 Inhibitor Lunresertib to Debiopharm in $267M Deal
10个月前
Repare Therapeutics Agrees to $1.82 Per Share Acquisition by XenoTherapeutics
7个月前
Paltusotine Poised for Major Market Impact as First Oral Acromegaly Therapy Gains FDA Approval
去年
Debiopharm and Oncodesign Services Partner to Advance Radiopharmaceutical Research with AbYlink™ Technology
11个月前
Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License
9个月前
Debiopharm Initiates Phase III Trial for Quarterly Acromegaly Treatment Debio 4126
8个月前
GARDP and Debiopharm Partner to Develop Novel First-in-Class Antibiotic for Multidrug-Resistant Gonorrhea
10个月前
Debiopharm Completes Enrollment for First-Ever Yearly Injectable Triptorelin Formulation in Pediatric Central Precocious Puberty Trial
5个月前
Debiopharm Reports First Clinical Data from MYTHIC Trial Combining WEE1 and PKMYT1 Inhibitors at AACR 2026
去年
Debiopharm Initiates First-in-Human Trial of CD37-Targeted ADC Debio 1562M for Relapsed/Refractory AML
第 1 页,共 475 页
上一页
下一页